C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2006
11/29/2006	CN1868545A Improved vaccines
11/29/2006	CN1286976C Interferon-alpha/beta binding protein, its preparation and use
11/29/2006	CN1286975C High affinity immunoglobulin for human antigen and heterologous tumour for manufacturing thereof
11/29/2006	CN1286973C Histone methyl transferase and its preparing method
11/29/2006	CN1286850C Process for preparing thymosin
11/29/2006	CN1286849C Soybean transcripting factor, its coding gene and use thereof
11/29/2006	CN1286535C Adsorbent for eliminating hepatitis C virus, adsorber, and adsorption method
11/29/2006	CN1286530C Self-regulated apoptosis of inflammatory cells by gene therapy
11/29/2006	CN1286524C Use of OPN for treatment and/or prevention of neurological diseases
11/28/2006	US7141720 Transcriptional factor enhancing the resistance of plants to osmotic stress
11/28/2006	US7141716 Major histocompatibility complex; transgenic swine
11/28/2006	US7141662 Diagnosis using antibodies; culture product
11/28/2006	US7141661 Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
11/28/2006	US7141656 In situ screening, isolation of peptides; major histocompability complex
11/28/2006	US7141652 Antibodies to PRO1561 polypeptide
11/28/2006	US7141651 Multiple cytokine protein complexes
11/28/2006	US7141650 Polypeptide useful in screening of agents for improving insulin resistance and glucose metabolism; receptor binding assays; skeletal muscle protein
11/28/2006	US7141649 Detection of agents which bind arrestin polypeptide; provide purified arrestin polypeptide, incubate with test a gent, detect preferential binding of test agent arrestin polypeptide
11/28/2006	US7141549 For diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins (SEC and NOV)
11/28/2006	US7141547 Albumin fusion proteins comprising GLP-1 polypeptides
11/28/2006	US7141546 CRFR2 selective ligands
11/28/2006	US7141543 Nucleic acid linked to transcriptional regulatory sequence; treating Rieger syndrome (RS), an autosomal dominant disorder of morphogenesis; eye vision defects, dental hypoplasia
11/28/2006	US7141541 Use of peptides
11/28/2006	US7141427 Regulatory element from a sugarcane proline rich protein and uses thereof
11/28/2006	US7141423 Constitutive promoter from arabidopsis
11/28/2006	US7141421 Control of metabolism with human 2-oxoglutarate carrier
11/28/2006	US7141420 Retina specific; for inhibition of macular degeneration
11/28/2006	US7141419 Isolated nucleic acids encoding cyclic nucleotide-gated cation channel subunit 3B (CNG3B) polypeptides
11/28/2006	US7141418 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments
11/28/2006	US7141408 live vector vaccine; removal of sole dependence on catalytic balanced lethal maintenance systems; plasmid partition system prevents random segregation; enhanced inheritance and stability; genetic engineering; antibiotic resistance
11/28/2006	US7141406 Using anion exchange chromatography to enrich for adenoviral nucleotide sequences
11/28/2006	US7141405 Hepatotropic flavivirus which is phylogenetic to human hepatitis C virus (GBV-B); drug screening
11/28/2006	US7141401 Protein complex for use in the treatment and prevention of lipid, cell proliferation, apoptosis, optic neuropathy, and inflammatory disorders
11/28/2006	US7141393 Interleukin-18-receptor proteins
11/28/2006	US7141392 Latent fusion protein
11/28/2006	US7141391 Monkey and canine melanin concentrating hormone receptors
11/28/2006	US7141390 Polynucleotide encoding human interleukin-17 receptor like molecule
11/28/2006	US7141389 Chromosome DNA coding for human hepatocyte growth factor
11/28/2006	US7141388 Nucleotide sequences for transcriptional regulation in corynebacterium glutamicum
11/28/2006	US7141383 EDG8 receptor, its preparation and use
11/28/2006	US7141381 Human leucine-rich repeat-containing proteins specifically expressed in the nervous system
11/28/2006	US7141379 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs
11/28/2006	US7141376 Carrier tests for polycystic kidney disease in the cat
11/28/2006	US7141375 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
11/28/2006	US7141367 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and respiratory disorders
11/28/2006	US7141365 Methods for diagnosing a mucin production associated disease condition
11/28/2006	US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006	US7141262 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents
11/28/2006	US7141244 Helicobacter pylori proteins useful for vaccines and diagnostics
11/28/2006	US7141243 gM-negative EHV-mutants without heterologous elements
11/28/2006	US7141242 Hepatitis B virus surface antigen mutant and methods of detection thereof
11/28/2006	US7141240 Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1
11/28/2006	US7141239 Growth/differentiation factor of the TGF-β family
11/28/2006	CA2208095C Generation of human insulin
11/28/2006	CA2114636C Recombinant plant viral nucleic acids
11/28/2006	CA2026915C Stem cell factor
11/28/2006	CA1341516C Preparation of factor x111a by gene manipulation
11/23/2006	WO2006124678A2 Corn plants and seed enhanced for asparagine and protein
11/23/2006	WO2006124667A2 Compositions and methods for modulating immune responses
11/23/2006	WO2006124537A1 Compounds that regulate apoptosis
11/23/2006	WO2006124529A1 Glp-1 pegylated compounds
11/23/2006	WO2006124152A2 Method for using a static electric field to induce crystallization and to control crystal form
11/23/2006	WO2006123827A1 Method for amelioration of disease condition induced by mood disorder
11/23/2006	WO2006122986A2 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
11/23/2006	WO2006122972A1 Interferon-beta gene therapy using an improved, regulated expression system
11/23/2006	WO2006122792A1 Peptides capable of modulating the function of tirc7
11/23/2006	WO2006122791A2 Tirc7 as marker for detecting early immune activation
11/23/2006	WO2006122652A2 Thiosuccinic acid derivatives and the use thereof
11/23/2006	WO2006122586A1 Pasteurella multocida vaccine
11/23/2006	WO2006122545A1 Animal model for the human immune system, and method for producing the same
11/23/2006	WO2006122404A1 Trappin-2 (elafin) inhibits hiv
11/23/2006	WO2006102188A3 Methods and compositions involving the s-ship promoter
11/23/2006	WO2006099037A3 A sporadic tumor mouse model for drug discovery
11/23/2006	WO2006097642A3 Composition comprising the n-terminal region of leishmania histone h2b, use thereof for inducing an immune response
11/23/2006	WO2006097564A3 Novel soluble epcr protein of non-proteolytic origin and use thereof
11/23/2006	WO2006096441A3 Reagents, methods and systems to suppress phospholamban expression
11/23/2006	WO2006091099A3 Non-glycosylated recombinant collagen-like polypeptides
11/23/2006	WO2006088833A3 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
11/23/2006	WO2006086188A3 Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
11/23/2006	WO2006084888A3 C-terminally pegylated growth hormones
11/23/2006	WO2006084705A3 Novel gene sts 06
11/23/2006	WO2006084704A3 Novel gene sts 01
11/23/2006	WO2006084703A3 Novel gene sts 24
11/23/2006	WO2006072368A3 Probe for detecting nucleic acids
11/23/2006	WO2006063067A3 Novel tnf receptor regulatory domain
11/23/2006	WO2006024880A3 Methods and compositions to inhibit p2x7 receptor expression
11/23/2006	WO2006005975B1 Homo and heterodimer proteins of the abcg family, methods for detection and screening modulators thereof
11/23/2006	WO2006004748B1 Improved corn fractionation method
11/23/2006	WO2005116267A3 Emission ratiometric indicators of phosphorylation by c-kinase
11/23/2006	WO2005113781A3 Vectors for use in gene and cancer therapy
11/23/2006	WO2005086967A3 Therapeutic use of rm1 antigen
11/23/2006	WO2005070180A3 Coccidian parasite casein kinase i as a chemotherapeutic target for antiprotozoal agents
11/23/2006	WO2005001052A3 Modulation of apoptosis
11/23/2006	US20060265783 growth modulators; modifying RKS genes or gene products as found in Arabidopsis thaliana or other plants; method for increasing organ size or rate of cell division of a plant or plant cell
11/23/2006	US20060265782 Novel plant transcribed regions and uses thereof
11/23/2006	US20060265779 Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors
11/23/2006	US20060265773 Methods for producing transgenic animals with modified disease resistance
11/23/2006	US20060265770 Transgenic mice containing glutamate receptor (GRIK5) gene disruptions
11/23/2006	US20060265769 Gab2 (p97) gene and methods of use thereof
11/23/2006	US20060264619 Plasmodium falciparum AMA-1 protein and uses thereof

1 ... 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 ... 2916